India Readies Medical Device Bill To Regulate Prices
This article was originally published in PharmAsia News
India's government is ready to introduce a new law to regulate the price of medical devices in the country. The Union Science and Technology minister said the draft to be presented soon to the cabinet would set stronger standards for device makers as well as set up certification procedures. The intent, he said, is to reduce health care costs by encouraging more local for imported devices. He said as much as 40 percent of health care costs can be attributed to diagnostic kits and other medical equipment. (Click here for more
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.